UK MHRA grants marketing authorization in the UK for Vimkunya vaccine for the prevention of disease caused by chikungunya virus in individuals 12 years and older – Bavarian Nordic
Bavarian Nordic A/S announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for Vimkunya (recombinant, adsorbed) for… read more.
